Maia Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2M Sell
4,103
-823
-17% -$270K 0.2% 132
2025
Q4
$1.66M Sell
4,926
-653
-12% -$221K 0.28% 103
2025
Q3
$1.69M Sell
5,579
-992
-15% -$309K 0.29% 100
2025
Q2
$2.56M Sell
6,571
-194
-3% -$78K 0.49% 52
2025
Q1
$2.98M Buy
6,765
+333
+5% +$134K 0.68% 38
2024
Q4
$2.65M Buy
6,432
+1,047
+19% +$438K 0.57% 40
2024
Q3
$2.26M Buy
5,385
+1,079
+25% +$576K 0.56% 43
2024
Q2
$2.29M Buy
+4,306
New +$2.28M 0.69% 38
2023
Q4
$1.37M Buy
+2,914
New +$1.35M 0.55% 43

Other funds holding ELV

Maia Wealth's ELV Position: Q1 2026 in Review

Maia Wealth reduced its Elevance Health (ELV) stake by 17% in Q1 2026, selling an estimated $270K and leaving 4,103 shares worth $1.2M. The position accounts for 0.2% of the portfolio, ranked #132.

Maia Wealth first reported a position in ELV in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.98M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Maia Wealth held 4,103 shares of Elevance Health worth $1.2M as of Q1 2026.
  • Maia Wealth sold 823 Elevance Health shares in Q1 2026, an estimated $270K.
  • Elevance Health made up 0.2% of Maia Wealth's portfolio in Q1 2026, its #132 holding.
  • Maia Wealth first reported a position in Elevance Health in Q4 2023 and has held it in 9 quarters since.
  • Maia Wealth's Elevance Health position peaked at $2.98M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Maia Wealth's 13F filing for Q1 2026, filed 8 May 2026.